ÂÜÀòÂÒÂ×

Emil deGoma serves as Senior Vice President of Medical Research at Tourmaline Bio since October 2023, following a role as Senior Consultant in Clinical Development at Radiem Consulting, LLC. Previous experience includes leadership positions at several biotechnology and pharmaceutical companies, such as Vice President of Clinical Development at Amgen and ChemoCentryx, and Vice President of Clinical Development at Exicure. Significant therapeutic areas of expertise encompass immunology, nephrology, and cardiovascular disease, with a robust history of managing clinical development activities, presenting to executive leadership, and authoring publications for international conferences. Emil's academic credentials include a Doctor of Medicine from Harvard Medical School and a Bachelor of Arts in Biochemical Sciences from Harvard University, alongside a tenure as an Assistant Professor at the Perelman School of Medicine at the University of Pennsylvania.